Clean Science and Technology Limited has announced the successful completion of product trials for its advanced grades of HALS products, developed by its wholly-owned subsidiary, Clean Fino-Chem Limited, in collaboration with Geneus Chem AG. These products have met stringent quality benchmarks and international standards, indicating optimum efficiency and commercial viability. This milestone is a significant step towards the planned commercial launch of this new product range in the second half of FY 2026-27, aligning with the company’s growth objectives and market expansion strategy.
Successful Product Trials and Future Launch
Clean Science and Technology Limited (CSTL) has officially reported the successful conclusion of product trials for a new range of advanced grades of Hindered Amine Light Stabilizer (HALS) products. These trials were conducted by its wholly-owned subsidiary, Clean Fino-Chem Limited (CFCL), in strategic collaboration with Geneus Chem AG. The successful completion of these trials marks a significant advancement for the company’s product development pipeline.
Product Performance and Viability
The newly developed HALS products have reportedly met CSTL’s internal quality benchmarks and adhered to applicable international regulatory standards. This validation demonstrates the products’ optimum efficiency and commercial viability, as per the agreed collaboration terms. The positive outcome of these trials is a critical precursor to the anticipated commercial launch of this innovative product line.
Strategic Market Expansion
The commercial launch of this new product range is projected to commence in the second half of the financial year 2026-27. The introduction of these advanced HALS products is a key component of CSTL’s strategic growth objectives. Furthermore, it is expected to significantly bolster the company’s efforts to expand its market presence and enhance its competitive standing in the specialty chemicals sector.
Source: BSE
